Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Safety and Immunogenicity Study of a New Formulation of the Locally-Produced Bivalent Killed, Whole-Cell Oral Cholera Vaccine in Vietnamese Subjects

NCT00128011 is registered in ClinicalTrials.gov with International Vaccine Institute as lead sponsor.

NCT NCT00128011
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00128011 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Safety and Immunogenicity Study of a New Formulation of the Locally-Produced Bivalent Killed, Whole-Cell Oral Cholera Vaccine in Vietnamese Subjects
Lead sponsor
International Vaccine Institute
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2005
Completion date
June 30, 2005
Enrollment
150
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cholera